Navigation Links
Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting
Date:10/23/2008

CALGARY, Oct. 23 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) today announced that an abstract entitled "Phase I Trial of Oncolytic Reovirus (REOLYSIN(R)) in Combination with Carboplatin/Paclitaxel in Patients with Advanced Solid Cancers" will be available in the November/December issue of the Journal of Immunotherapy, the official journal of the International Society for Biological Therapy of Cancer (iSBTc). The principal investigator for the trial is Dr. Kevin Harrington of The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust.

The abstract covers results of the trial (REO 011) up to July 2008. At that time, 11 patients had received 46 cycles of treatment, with no dose-limiting toxicities. Of the 10 evaluable patients, there were three patients with a partial response, five patients with stable disease and two patients with progressive disease. On the basis of promising response data in the patients with head and neck cancers, a Phase II study has been opened in head and neck cancer patients using the 3x10(10) TCID(50) dose on five consecutive days.

A poster presentation that will include current results of the trial is scheduled to be presented on November 1, 2008 at the iSBTc annual meeting. The meeting is being held in San Diego, California from October 31-November 2, 2008.

The poster should be available on the Oncolytics website at http://www.oncolyticsbiotech.com on November 3, 2008.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visi
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...erman . , Whether it,s CD packaging, contain...uency Identification) are increasingly finding the...o label objects or goods and identify them automat... can read and process the data contained in the la...oduction conditions of up to 100 degrees Celsius. ...
(Date:11/24/2009)...York investment bank KTA Capital,s client Neuren P...mil convertible note private placement with a U.S.... arranged by KTA Capital as Neuren,s exclusive pla... New York (PRWEB) November 23, 2009 -- The indep..."KTA Capital") has announced that its cl...
(Date:11/24/2009)...24/PRNewswire-FirstCall/--deCODE,genetics,Inc.(Nas...om,theNasdaqStockMarketthattradinginthecompany,sco...rm25-NSEwillbefiledwiththe,SecuritiesandExchangeCo...stingonNasdaq,unlessthecompanyfilesanappealtotheNa...suchanappeal,which,willstaythesuspensionanddelisti...
(Date:11/24/2009)...24/PRNewswire-FirstCall/--deCODE,genetics,Inc.(Nas...rstday"motionsbytheU.S.BankruptcyCourtfortheDistri...filedavoluntarypetitionfor,reliefunderChapter11oft...t. , TheordersissuedbytheBankruptcyCourtallow...Chapter11proceedings.Inparticular,the,companyrecei...
Breaking Biology Technology:Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
...S, Missouri, March 31 , - Books Authored by N...biggest names in health care publishing, the Ameri...nounced an exclusive agreement to,co-publish Inter...n, Clinical,Modification (ICD-9-CM) and Healthcare... Carol J. Buck, beginning with the 2010 editions, ...
... March 31 Viroblock SA has announced,today that t...pray,formulation is active against human influenza...tion Technology (VCCD Tech) inactivates enveloped,...ng and destabilizing,cholesterol-rich viral envelo...rrets to Influenza A,Wisconsin/67/2005 and influen...
... ImQuest Life Sciences today presented important ...rimidinedione small molecules as antiviral agents ...itis and Liver Disease meeting held last week in W...dentified ten pyrimidinediones as inhibitors of HB...inhibition of HBV replication at sub-micromolar co...
Other Biology Technology:The American Medical Association and Elsevier Join to Co-Publish ICD-9-CM and HCPCS Coding Reference Books 2The American Medical Association and Elsevier Join to Co-Publish ICD-9-CM and HCPCS Coding Reference Books 3Viroblock SA Reports Positive Results of Preclinical Studies in Antiviral Nasal Spray 2ImQuest Presents Data on the Anti-Hepatitis B Virus Activity of Pyrimidinediones at the 13th ISVHLD Meeting in Washington D.C. 2
(Date:11/24/2009)... Spanish . , The presence of increased body...substances in the blood, hinders the loss and main...ject of the University of Navarra conducted by Est...f Pharmacy. , The project, entitled "A nutrigene...rol of body weight and inflammation," examines how...
(Date:11/23/2009)...- The time of day matters to forest trees dealing ... a research team led by Professor Malcolm Campbell...al for research and colleagues in the department o...s. , Capitalizing on their previous work to de...eam examined how poplar trees use their 45,000 gen...
(Date:11/23/2009)...y provides "incontrovertible evidence" that the vo...atra about 73,000 years ago deforested much of cen...esearchers report. , The volcano ejected an esti...ere, leaving a crater (now the world,s largest vol...ometers wide. Ash from the event has been found in...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2Time of day matters to thirsty trees, U of T researcher discovers 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Reportlinker Adds Membrane Bioreactors Report 13907 1Reportlinker Adds Membrane Bioreactors Report 13907 2Reportlinker Adds Membrane Bioreactors Report 13907 3Reportlinker Adds Membrane Bioreactors Report 13907 4Reportlinker Adds Membrane Bioreactors Report 13907 5Reportlinker Adds Membrane Bioreactors Report 13907 6Reportlinker Adds Membrane Bioreactors Report 13907 7Reportlinker Adds Membrane Bioreactors Report 13907 8Reportlinker Adds Membrane Bioreactors Report 13907 9Reportlinker Adds Membrane Bioreactors Report 13907 10Reportlinker Adds Membrane Bioreactors Report 13907 11Reportlinker Adds Membrane Bioreactors Report 13907 12Reportlinker Adds Membrane Bioreactors Report 13907 13Reportlinker Adds Membrane Bioreactors Report 13907 14Reportlinker Adds Autoimmune Disease Therapeutics Report 56428 1Reportlinker Adds Autoimmune Disease Therapeutics Report 56428 2Reportlinker Adds Autoimmune Disease Therapeutics Report 56428 3Reportlinker Adds Autoimmune Disease Therapeutics Report 56428 4Reportlinker Adds Autoimmune Disease Therapeutics Report 56428 5Reportlinker Adds Autoimmune Disease Therapeutics Report 56428 6Reportlinker Adds Autoimmune Disease Therapeutics Report 56428 7Reportlinker Adds Autoimmune Disease Therapeutics Report 56428 8Reportlinker Adds Autoimmune Disease Therapeutics Report 56428 9Reportlinker Adds Autoimmune Disease Therapeutics Report 56428 10Reportlinker Adds Autoimmune Disease Therapeutics Report 56428 11Reportlinker Adds Autoimmune Disease Therapeutics Report 56428 12Reportlinker Adds Autoimmune Disease Therapeutics Report 56428 13Reportlinker Adds Autoimmune Disease Therapeutics Report 56428 14Favorite California Firehouse Recipes Fill New Cookbook 56425 1Favorite California Firehouse Recipes Fill New Cookbook 56425 2Favorite California Firehouse Recipes Fill New Cookbook 56425 3Favorite California Firehouse Recipes Fill New Cookbook 56425 4Favorite California Firehouse Recipes Fill New Cookbook 56425 5Favorite California Firehouse Recipes Fill New Cookbook 56425 6
...Columbia scientists have traced the fragrant scent...he anthers, contrary to common perception that pet...s used to produce Cabernet Sauvignon from the Okan...UBC,s Wine Research Centre and Michael Smith Labor...tes fragrance from the vines, tiny clusters of gre...
...(April 6, 2009) Cell Press, an imprint of Elsevie...l , as well as Current Biology and The American...Special Library Association,s (SLA) Top 100 Journa... The Top 100 list is compiled by the 680-plus memb...sion (DBIO) on the most influential journals in bi...
...lectric ion propulsion system has been switched on...nother crucial milestone in the satellite,s post-l...s ultra-sensitive gravity measurements depends on .... The push from the thruster must be just enough t... by the few wisps of atmosphere at GOCE,s orbital ...
Other Biology News:Three prominent Cell Press journals named among the 100 most influential journals in past 100 years 2GOCE's electric ion propulsion engine switched on 2
Sheep Anti-Human Factor XIII Antibody, Horseradish Peroxidase Conjugated from CEDARLANE Laboratories Limited
Immunoblot Blocking Reagent from Upstate
Rabbit Anti-DAP12 Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.
Amido Black 10B, CI 20470 from Research Organics, Inc.
Biology Products: